These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 969563)

  • 1. Peculiar pharmacokinetics of brallobarbital as a source of complications in Vesparax intoxication.
    Yih TD; Rossum JM
    Xenobiotica; 1976 Jun; 6(6):355-62. PubMed ID: 969563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of midazolam and vesparax in treatment of sleep disorders.
    Fischbach R
    Br J Clin Pharmacol; 1983; 16 Suppl 1(Suppl 1):167S-171S. PubMed ID: 6138072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of the use of hemoperfusion in acute poisoning.
    de Groot G; Maes RA; van Heijst AN
    Vet Hum Toxicol; 1979; 21 Suppl():8-11. PubMed ID: 505996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of midazolam and vesparax in moderate or severe insomnia in female surgical patients.
    Philipp E; Kapp W
    Br J Clin Pharmacol; 1983; 16 Suppl 1(Suppl 1):161S-165S. PubMed ID: 6138071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Death through injection of barbiturates.
    Noirfalise A; Dodinval P; Quiriny J; Schreiber H
    Forensic Sci Int; 1987; 35(2-3):141-4. PubMed ID: 2892764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Medical malpractice in the poisoning of drug addicts with Vesparax].
    Aderjan R; Barz J; Bösche J; Mattern R; Schmidt G
    Acta Med Leg Soc (Liege); 1983; 33(2):1111-8. PubMed ID: 6137131
    [No Abstract]   [Full Text] [Related]  

  • 7. [Controlled clinical evaluation of a combination of barbiturates and hydroxyzine].
    Gainotti
    Acta Anaesthesiol Belg; 1967; 18(2):149-54. PubMed ID: 5623558
    [No Abstract]   [Full Text] [Related]  

  • 8. [Results of toxicological investigations on vesparax-poisonings (author's transl)].
    Sticht G; Käferstein H
    Z Rechtsmed; 1980; 85(3):169-75. PubMed ID: 7415572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxyzine and cetirizine pharmacokinetics and pharmacodynamics after oral and intravenous administration of hydroxyzine to healthy dogs.
    Bizikova P; Papich MG; Olivry T
    Vet Dermatol; 2008 Dec; 19(6):348-57. PubMed ID: 18980631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [CLINICAL APPLICATION OF A NEW VERY ACTIVE HYPNOTIC ASSOCIATING SODIUM SECOBARBITAL, CALCIUM BRALLOBARBITAL AND HYDROXYZINE (UC-8130)].
    LHERMANN J
    Gaz Med Fr; 1964 Mar; 71():961-2. PubMed ID: 14142825
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug interactions of the components of Optalidon after oral administration.
    Lavene D; Longchampt J; Guillaume MF; Kiger JL
    Int J Clin Pharmacol Biopharm; 1976 Jun; 13(4):235-45. PubMed ID: 965130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A toxicological evaluation of different adsorbents in hemoperfusion.
    De Groot G; Maes RA; Van Heijst AN
    Clin Toxicol; 1981 Oct; 18(10):1199-211. PubMed ID: 6122529
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetics and relative bioavailability of vinylbital in man after oral and rectal administration.
    Breimer DD; de Boer AG
    Arzneimittelforschung; 1976; 26(3):448-54. PubMed ID: 989344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of simultaneously administered hexobarbital and heptabarbital in rats: an alternative approach to metabolic correlation studies.
    van der Graaff M; Vermeulen NP; Langendijk PN; Breimer DD
    J Pharmacol Exp Ther; 1983 Jun; 225(3):747-51. PubMed ID: 6134816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The disposition of valpromide in rats and the isolated perfused rat liver.
    Billig H; Ziv E; Bar-On H; Bialer M
    Drug Metab Dispos; 1990; 18(2):238-44. PubMed ID: 1971580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of alpha-dihydroergocryptine in rats after intravenous and oral administration.
    Grognet JM; Istin M; Zanotti A; Mailland F; Coppi G
    Arzneimittelforschung; 1991 Jul; 41(7):689-91. PubMed ID: 1772454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-dependent pharmacokinetics of 1-(2-deoxy-beta-D- ribofuranosyl)-2,4-difluoro-5-iodobenzene: a potential mimic of 5-iodo-2'-deoxyuridine.
    Khalili P; Naimi E; Sun WY; Knaus EE; Wiebe LI
    Biopharm Drug Dispos; 2003 Dec; 24(9):385-95. PubMed ID: 14689467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
    Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H
    Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the pharmacokinetics of hawthorn phenolics in extract versus individual pure compound.
    Chang Q; Zuo Z; Ho WK; Chow MS
    J Clin Pharmacol; 2005 Jan; 45(1):106-12. PubMed ID: 15601812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of radiolabelled quinlukast in rats.
    Syrovatko M; Laznickova A; Laznicek M
    J Pharm Biomed Anal; 2005 Jun; 38(2):313-9. PubMed ID: 15925224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.